Last Posted: Apr 10, 2021
- High nocturnal sleep fragmentation is associated with low T lymphocyte P2Y11 protein levels in narcolepsy type 1.
Viste Rannveig, et al. Sleep 2021 3
- Histamine H receptor gene variants associated with drug abuse in patients with cocaine use disorder.
Pallardo-Fernández Iñigo, et al. Journal of psychopharmacology (Oxford, England) 2020 10 269881120961253
- The impact of the HLA DQB1 gene and amino acids on the development of narcolepsy.
Kachooei-Mohaghegh-Yaghoobi Leila et al. The International journal of neuroscience 2020 Oct 1-11
- Differences in clinical and genetic characteristics between early- and late-onset narcolepsy in a Han Chinese cohort.
Ouyang Hui, et al. Neural regeneration research 2020 10 (10) 1887-1893
- HLA and sleep parameter associations in post-H1N1 narcolepsy type 1 patients and first-degree relatives.
Juvodden Hilde T, et al. Sleep 2019 10
- HLA high-resolution typing by next-generation sequencing in Pandemrix-induced narcolepsy.
Lind Alexander, et al. PloS one 2019 0 (10) e0222882
- Computer Algorithms in Assessment of Obstructive Sleep Apnoea Syndrome and Its Application in Estimating Prevalence of Sleep Related Disorders in Population.
Katyayan Angira et al. Indian journal of otolaryngology and head and neck surgery : official publication of the Association of Otolaryngologists of India 2019 Sep 71(3) 352-359
- Fine-mapping of the human leukocyte antigen locus as a risk factor for Alzheimer disease: A case-control study.
Steele Natasha Z R, et al. PLoS medicine 2017 3 (3) e1002272
- Correlation between HLA-DQB1*06:02 and narcolepsy with and without cataplexy: approving a safe and sensitive genetic test in four major ethnic groups. A systematic meta-analysis.
Capittini C, et al. Sleep medicine 2018 12 150-157
- Precision Medicine for Idiopathic Hypersomnia.
Arnulf Isabelle et al. Sleep medicine clinics 2019 Sep 14(3) 333-350
Rare Disease PHGKB is an online, continuously updated, searchable database of published scientific literature, CDC and NIH resources, and other information that address the public health impact and translation of genomic and other precision health discoveries into improved health outcomes related to rare diseases...more
Selected Rare Diseases
- Alpha-1 Antitrypsin Deficiency
- Amyotrophic Lateral Sclerosis
- Brugada Syndrome
- Cerebral Palsy
- Cystic Fibrosis
- Duchenne Muscular Dystrophy
- Erythema Multiforme
- Familial Mediterranean Fever
- Fragile X Syndrome
- Gaucher Disease
- Graves Disease
- Huntington Disease
- Myasthenia Gravis
- Retinitis Pigmentosa
- Severe Combined Immunodeficiency
Disclaimer: Articles listed in the Public Health Knowledge Base are selected by the CDC Office of Public Health Genomics to provide current awareness of the literature and news. Inclusion in the update does not necessarily represent the views of the Centers for Disease Control and Prevention nor does it imply endorsement of the article's methods or findings. CDC and DHHS assume no responsibility for the factual accuracy of the items presented. The selection, omission, or content of items does not imply any endorsement or other position taken by CDC or DHHS. Opinion, findings and conclusions expressed by the original authors of items included in the update, or persons quoted therein, are strictly their own and are in no way meant to represent the opinion or views of CDC or DHHS. References to publications, news sources, and non-CDC Websites are provided solely for informational purposes and do not imply endorsement by CDC or DHHS.